Zymeworks Completes $929M Theravance Biopharma Acquisition
Vancouver, British Columbia, September 23, 2026 Zymeworks Inc. has completed its previously announced acquisition of Theravance Biopharma, Inc., bringing...
pharmaceutical M&A
Advertisement
Grünenthal Acquires Stivarga Cancer Treatment From Bayer
Aachen, Germany, September 21, 2026 Grünenthal has announced an agreement with Bayer AG to acquire Stivarga® (regorafenib), an established...
Hanmi Pharm Licenses Obesity Drug HM17321 to Genentech
SEOUL, South Korea, August 24, 2026 Hanmi Pharm announced an exclusive global licensing agreement with Genentech, a member of...
Protagenic Advances PT00114 Toward FDA IND Submission
New York, New York, USA, August 20, 2026 Protagenic Therapeutics, a clinical-stage biopharmaceutical company developing peptide-based treatments for stress-related...
Werewolf Therapeutics and Ambros Announce $150M Merger
Waltham, Massachusetts, USA, and San Diego, California, USA, August 21, 2026 Werewolf Therapeutics and Ambros Therapeutics have announced a...
Advertisements
Bracco Gains FDA Clearance for VueJect Cardiac Imaging System
MILAN, Italy, August 11, 2026 Bracco Imaging has announced that its VueJect® ultrasound contrast delivery system has received 510(k)...
Alfasigma to Acquire Nordic Pharma in European M&A Deal
BOLOGNA AND MILAN, Italy, August 13, 2026 Alfasigma S.p.A. has entered into a share purchase agreement with SEVER Life...
Assertio Finalizes Merger with Zydus Lifesciences and Delists from Nasdaq
LAKE FOREST, Ill., June 16, 2026 Assertio Holdings, Inc. announced the successful completion of its previously announced merger with...
CVC and GBL Launch €10.7B Bid to Take Recordati Private
Milan, Italy, May 22, 2026 A consortium led by CVC Capital Partners IX and Groupe Bruxelles Lambert (GBL) has...
Sanofi to Acquire Dynavax, Expanding Adult Vaccine Pipeline
Paris, France | December 24, 2025 — Sanofi announced that it has entered into a definitive agreement to acquire...
Advertisement
